中国药理学通报
中國藥理學通報
중국약이학통보
CHINESE PHARMACOLOGICAL BULLETIN
2015年
4期
542-548,549
,共8页
朱世璟%袁媛%尹华阳%惠爱玲%周安%潘见
硃世璟%袁媛%尹華暘%惠愛玲%週安%潘見
주세경%원원%윤화양%혜애령%주안%반견
银杏内酯 B%前体药物%脑靶向%脑缺血%脂水分配系数%P-糖蛋白%ATP 酶活性
銀杏內酯 B%前體藥物%腦靶嚮%腦缺血%脂水分配繫數%P-糖蛋白%ATP 酶活性
은행내지 B%전체약물%뇌파향%뇌결혈%지수분배계수%P-당단백%ATP 매활성
ginkgolide B%prodrug%brain targeting%cerebral ischemia%lipo-hydropartition coefficient%P-glycoprotein%ATPase activity
目的:考察银杏内酯 B 前体药物(PGB)的脑靶向性,并探究其靶向机制。方法采用 LC-MS /MS 考察大鼠尾静脉注射 PGB 后的脑部药动学规律并评价其脑靶向性;采用伊文斯蓝法观察 PGB 对不完全性脑缺血小鼠脑毛细血管通透性的影响;HPLC 法测定 PGB 在正辛醇-水体系的分配系数(logP);MVD 分子对接软件计算 PGB 与 P-糖蛋白(P-gp)的体外结合力;定磷法检测 PGB 对人 P-gp 膜 ATP 酶活性的影响。结果以治疗有效性和靶向指数评价 PGB 的脑靶向效率达6.87和4.14;PGB 预防给药可有效降低不完全性脑缺血小鼠的脑毛细血管通透性(P <0.05);PGB 的 logP 为1.03,高于 GB 的0.61;分子对接计算表明 PGB 与 P-gp 结合力大于 GB,其 MolDockScore 分别为-143.36、-116.40 KJ ·mol -1;ATP 酶活性分析提示 PGB、GB 均能提高 P-gp ATP酶活性,其 Km 值分别为237.75、841.24μmol·L -1,PGB 与P-gp 亲和力高于 GB。结论PGB 具有脑靶向性,其靶向性提高一方面得益于其脂溶性提高,PGB 在脑部渗透量增加;另一方面可能为 PGB 明显提高 P-gp ATP 酶活性,从而抑制P-gp 对 GB 的外排作用。
目的:攷察銀杏內酯 B 前體藥物(PGB)的腦靶嚮性,併探究其靶嚮機製。方法採用 LC-MS /MS 攷察大鼠尾靜脈註射 PGB 後的腦部藥動學規律併評價其腦靶嚮性;採用伊文斯藍法觀察 PGB 對不完全性腦缺血小鼠腦毛細血管通透性的影響;HPLC 法測定 PGB 在正辛醇-水體繫的分配繫數(logP);MVD 分子對接軟件計算 PGB 與 P-糖蛋白(P-gp)的體外結閤力;定燐法檢測 PGB 對人 P-gp 膜 ATP 酶活性的影響。結果以治療有效性和靶嚮指數評價 PGB 的腦靶嚮效率達6.87和4.14;PGB 預防給藥可有效降低不完全性腦缺血小鼠的腦毛細血管通透性(P <0.05);PGB 的 logP 為1.03,高于 GB 的0.61;分子對接計算錶明 PGB 與 P-gp 結閤力大于 GB,其 MolDockScore 分彆為-143.36、-116.40 KJ ·mol -1;ATP 酶活性分析提示 PGB、GB 均能提高 P-gp ATP酶活性,其 Km 值分彆為237.75、841.24μmol·L -1,PGB 與P-gp 親和力高于 GB。結論PGB 具有腦靶嚮性,其靶嚮性提高一方麵得益于其脂溶性提高,PGB 在腦部滲透量增加;另一方麵可能為 PGB 明顯提高 P-gp ATP 酶活性,從而抑製P-gp 對 GB 的外排作用。
목적:고찰은행내지 B 전체약물(PGB)적뇌파향성,병탐구기파향궤제。방법채용 LC-MS /MS 고찰대서미정맥주사 PGB 후적뇌부약동학규률병평개기뇌파향성;채용이문사람법관찰 PGB 대불완전성뇌결혈소서뇌모세혈관통투성적영향;HPLC 법측정 PGB 재정신순-수체계적분배계수(logP);MVD 분자대접연건계산 PGB 여 P-당단백(P-gp)적체외결합력;정린법검측 PGB 대인 P-gp 막 ATP 매활성적영향。결과이치료유효성화파향지수평개 PGB 적뇌파향효솔체6.87화4.14;PGB 예방급약가유효강저불완전성뇌결혈소서적뇌모세혈관통투성(P <0.05);PGB 적 logP 위1.03,고우 GB 적0.61;분자대접계산표명 PGB 여 P-gp 결합력대우 GB,기 MolDockScore 분별위-143.36、-116.40 KJ ·mol -1;ATP 매활성분석제시 PGB、GB 균능제고 P-gp ATP매활성,기 Km 치분별위237.75、841.24μmol·L -1,PGB 여P-gp 친화력고우 GB。결론PGB 구유뇌파향성,기파향성제고일방면득익우기지용성제고,PGB 재뇌부삼투량증가;령일방면가능위 PGB 명현제고 P-gp ATP 매활성,종이억제P-gp 대 GB 적외배작용。
Aim To investigate the brain targeting of ginkgolide B prodrug (PGB ) and its mechanism. Methods The liquid chromatography tandem mass spectrometry (LC-MS /MS)method was applied to in-vestigate the pharmacokinetics of PGB in rat brain tis-sue after intravenous injection of PGB.Also the brain targeting was evaluated on the basis of the pharmacoki-netic parameter of PGB.The incomplete cerebral is-chemia model was induced in mouse,the effect of PGB on cerebral capillary permeability was observed by Ev-ans blue method.High performance liquid chromatog-raphy (HPLC)was used to determine the partition co-efficients (logP)of PGB in octanol-water system.PGB and P-glycoprotein (P-gp)was docked by using Mole-gro Virtual Docker (MVD)software to predict its bind-ing abilities with P-gp.The interaction of PGB with ATPase activity of human P-gp membrane was esti-mated by measuring inorganic phosphate liberation. Results The brain targeting of PGB was evaluated by treatment effective (TA ) and drug targeting index (DTI),the calculated value were 6.87 and 4.1 4 re-spectively.Preventive medication of PGB could signifi-cantly decrease cerebral capillary permeability (P <0.05).The lipo-hydropartition coefficient of PGB was higher than that of GB,their logP data were 1 .03 and 0.61 respectively.PGB displayed the stronger binding affinity with P-gp than GB according to the molecular docking calculations,their MolDock Score toward P-gp were -1 43.36 and -1 1 6.40KJ·mol -1 respectively. ATP-hydrolisis showed that PGB increased ATPase activity with a Km of approximately 237.75 μmol · L -1 ,however GB with a Km of approximately 841 .24μmol·L -1 .PGB might interact with P-gp with a high-er affinity and exhibit more effect than GB.Conclu-sion PGB is characterized by its brain targeting. Higher liposolubility of PGB results in good blood-brain permeability,which is advantageous to its brain targe-ting.Besides,PGB can effectively inhibit the efflux effect of P-gp to GB because of its increased P-gp AT-Pase activity.